Search

Your search keyword '"Yu, Zhengtian"' showing total 40 results

Search Constraints

Start Over You searched for: Author "Yu, Zhengtian" Remove constraint Author: "Yu, Zhengtian"
40 results on '"Yu, Zhengtian"'

Search Results

8. Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation

9. Cover Image, Volume 12, Issue 4

11. Discovery of the Clinical Candidate MAK683: An EED-Directed, Allosteric, and Selective PRC2 Inhibitor for the Treatment of Advanced Malignancies

15. Along the allostery stream: Recent advances in computational methods for allosteric drug discovery.

17. Discovery of Potent and Selective Allosteric Inhibitors of Protein Arginine Methyltransferase 3 (PRMT3)

18. Abstract LB-288: An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED

19. Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer Efficacy

20. An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED

21. Discovery and Molecular Basis of a Diverse Set of Polycomb Repressive Complex 2 Inhibitors Recognition by EED

22. Histone methyltransferase SETDB1 regulates liver cancer cell growth through methylation of p53

23. A Potent, Selective and Cell-Active Allosteric Inhibitor of Protein Arginine Methyltransferase 3 (PRMT3)

24. Abstract 2930: Global chromatin profiling reveals NSD2 mutation in pediatric ALL

26. Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia

27. Discovery of thieno[2,3- c]pyridines as potent COT inhibitors

38. Polymerizations of olefins and diolefins catalyzed by monocyclopentadienyltitanium complexes containing a (dimethylamino)ethyl substituent and comparison with <TOGGLE>ansa</TOGGLE>-zirconocene systems

40. Histone methyltransferase SETDB1 regulates liver cancer cell growth through methylation of p53.

Catalog

Books, media, physical & digital resources